贝伐单抗-adcd的分子量大约为149 kDa。贝伐单抗-adcd在哺乳动物细胞(中国仓鼠卵巢)表达系统中产生。 Vegzelma (bevacizumab-adcd)注射液是一种无菌、不含防腐剂、澄清至乳白色、无色至浅棕色的溶液,装在单剂量小瓶中,供静脉注射使用。Vegzelma含有浓度为25毫克/毫升的贝伐单抗-adcd,装在100毫克/4毫升或400毫克/...
FDA approval for its oncology biosimilar Vegzelma® (bevacizumab-adcd) for the treatment of six types of cancer · Vegzelma® is Celltrion’s third oncology biosimilar to receive approval from the U.S. FDA · Vegzelma® offers U.S. patients living with multiple types of cancer a new,...
Purpose of Study: Intravitreal bevacizumab (IVB) is rapidly replacing laser therapy as the treatment of choice for infants with retinopathy of prematurity (ROP), but its systemic effects on the developing child remain largely unknown. The purpose of this study is to determine whether infants with ...